This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Look: Reviewing the recent FDA approval of Boston Scientific's POLARx cryoablation system for atrial fibrillation

Ticker(s): BSX, MDT, JNJ

Who's the expert?

Institution: Oregon Health & Science University

  • Assistant Professor of Medicine and Director of the Atrial Fibrilaltion Program at OHSU
  • Manages over 50 patients with AFib 
  • Special expertise in complex ablations and management of implantable cardiac devices

Interview Questions
Q1.

Describe your background and practice setting

Added By: ben_admin
Q2.

How many patients with AFib do you manage?

Added By: ben_admin
Q3.

How many different cryoablation systems do you utilize in practice?

Added By: ben_admin
Q4.

What is your opinion on the recent approval of BSX POLARx system?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.